Antigen escape in CAR-T cell therapy: Mechanisms and overcoming strategies.
Biomed Pharmacother
; 178: 117252, 2024 Sep.
Article
en En
| MEDLINE
| ID: mdl-39098176
ABSTRACT
Chimeric antigen receptor T (CAR-T) cell therapy has shown promise in treating hematological malignancies and certain solid tumors. However, its efficacy is often hindered by negative relapses resulting from antigen escape. This review firstly elucidates the mechanisms underlying antigen escape during CAR-T cell therapy, including the enrichment of pre-existing target-negative tumor clones, antigen gene mutations or alternative splicing, deficits in antigen processing, antigen redistribution, lineage switch, epitope masking, and trogocytosis-mediated antigen loss. Furthermore, we summarize various strategies to overcome antigen escape, evaluate their advantages and limitations, and propose future research directions. Thus, we aim to provide valuable insights to enhance the effectiveness of CAR-T cell therapy.
Palabras clave
Texto completo:
1
Base de datos:
MEDLINE
Asunto principal:
Inmunoterapia Adoptiva
/
Receptores Quiméricos de Antígenos
/
Antígenos de Neoplasias
/
Neoplasias
Idioma:
En
Revista:
Biomed Pharmacother
Año:
2024
Tipo del documento:
Article